Medgenics Inc (NYSE MKT LLC:MDGN)

9.10
Delayed Data
As of Apr 20
 -0.03 / -0.33%
Today’s Change
3.68
Today|||52-Week Range
9.63
+79.84%
Year-to-Date

Stock Price Forecast

The 2 analysts offering 12-month price forecasts for Medgenics Inc have a median target of 15.00, with a high estimate of 15.00 and a low estimate of 15.00. The median estimate represents a +64.83% increase from the last price of 9.10.

Analyst Recommendations

The current consensus among 2 polled investment analysts is to Buy stock in Medgenics Inc. This rating has held steady since April, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.20
Sales
$1.2M
Reporting Date
Aug 17

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 44.44%
 
 
 
 
 
 
Growthannually -31.00%
 
 
 
 
 
 

Sales

Growthquarterly --
 
 
 
 
 
 
Growthannually 0.58%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.

To view my watchlist

Not a member yet?

Sign up now for a free account